Let Drugmakers Create Their Own REMS to Foster Generics, Says CVS

Drug Industry Daily
A A
To curb abuse of the Hatch-Waxman system, the FDA should consider allowing generic drug manufacturers to create their own REMS, according to CVS Health.

To View This Article:

Login

Subscribe To Drug Industry Daily